Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Alcon Research0 sites690 target enrollmentOctober 2004

ConditionsOpen-angle Glaucoma Ocular Hypertension

DrugsTravoprost 0.004% with and without BAK

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Open-angle Glaucoma
Sponsor: Alcon Research
Enrollment: 690
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Registry

clinicaltrials.gov

Start Date

October 2004

End Date

June 2005

Last Updated

13 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Alcon Research

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult subjects of either sex and any race 18 years or older with open-angle glaucoma or ocular hypertension. Patients with logMAR visual acuity not worse than 0.6 in either eye or any clinically relevant ophthalmic/systemic condition will be excluded.